277 related articles for article (PubMed ID: 19204198)
1. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
Le Scodan R; Stevens D; Brain E; Floiras JL; Cohen-Solal C; De La Lande B; Tubiana-Hulin M; Yacoub S; Gutierrez M; Ali D; Gardner M; Moisson P; Villette S; Lerebours F; Munck JN; Labib A
J Clin Oncol; 2009 Mar; 27(9):1375-81. PubMed ID: 19204198
[TBL] [Abstract][Full Text] [Related]
2. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
[TBL] [Abstract][Full Text] [Related]
3. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis.
Rapiti E; Verkooijen HM; Vlastos G; Fioretta G; Neyroud-Caspar I; Sappino AP; Chappuis PO; Bouchardy C
J Clin Oncol; 2006 Jun; 24(18):2743-9. PubMed ID: 16702580
[TBL] [Abstract][Full Text] [Related]
4. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
5. Effects of surgical excision on survival of patients with stage IV breast cancer.
Leung AM; Vu HN; Nguyen KA; Thacker LR; Bear HD
J Surg Res; 2010 Jun; 161(1):83-8. PubMed ID: 19375721
[TBL] [Abstract][Full Text] [Related]
6. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.
Babiera GV; Rao R; Feng L; Meric-Bernstam F; Kuerer HM; Singletary SE; Hunt KK; Ross MI; Gwyn KM; Feig BW; Ames FC; Hortobagyi GN
Ann Surg Oncol; 2006 Jun; 13(6):776-82. PubMed ID: 16614878
[TBL] [Abstract][Full Text] [Related]
7. The role of surgery in breast cancer patients with isolated bone metastases at the time of diagnosis.
Turanli S
J Surg Oncol; 2009 Aug; 100(2):95-9. PubMed ID: 19384913
[TBL] [Abstract][Full Text] [Related]
8. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma.
Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T
Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123
[TBL] [Abstract][Full Text] [Related]
9. Association of surgery with improved survival in stage IV breast cancer patients.
Blanchard DK; Shetty PB; Hilsenbeck SG; Elledge RM
Ann Surg; 2008 May; 247(5):732-8. PubMed ID: 18438108
[TBL] [Abstract][Full Text] [Related]
10. Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation.
Panoff JE; Takita C; Hurley J; Reis IM; Zhao W; Rodgers SE; Gunaseelan V; Wright JL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1192-9. PubMed ID: 21514739
[TBL] [Abstract][Full Text] [Related]
11. DNA repair gene expression and risk of locoregional relapse in breast cancer patients.
Le Scodan R; Cizeron-Clairac G; Fourme E; Meseure D; Vacher S; Spyratos F; de la Lande B; Cvitkovic F; Lidereau R; Bieche I
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):328-36. PubMed ID: 20092964
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrence in breast carcinoma patients.
Yildirim E
Eur J Surg Oncol; 2009 Mar; 35(3):258-63. PubMed ID: 18644692
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence.
Kuo SH; Huang CS; Kuo WH; Cheng AL; Chang KJ; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1456-64. PubMed ID: 18692329
[TBL] [Abstract][Full Text] [Related]
14. Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation.
Abramowitz MC; Li T; Morrow M; Sigurdson ER; Anderson P; Nicolaou N; Freedman G
Am J Clin Oncol; 2009 Feb; 32(1):30-3. PubMed ID: 19194121
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis.
Ruiterkamp J; Ernst MF; van de Poll-Franse LV; Bosscha K; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2009 Nov; 35(11):1146-51. PubMed ID: 19398188
[TBL] [Abstract][Full Text] [Related]
16. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis.
Fields RC; Jeffe DB; Trinkaus K; Zhang Q; Arthur C; Aft R; Dietz JR; Eberlein TJ; Gillanders WE; Margenthaler JA
Ann Surg Oncol; 2007 Dec; 14(12):3345-51. PubMed ID: 17687611
[TBL] [Abstract][Full Text] [Related]
17. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.
Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer with synchronous metastases: trends in survival during a 14-year period.
Andre F; Slimane K; Bachelot T; Dunant A; Namer M; Barrelier A; Kabbaj O; Spano JP; Marsiglia H; Rouzier R; Delaloge S; Spielmann M
J Clin Oncol; 2004 Aug; 22(16):3302-8. PubMed ID: 15310773
[TBL] [Abstract][Full Text] [Related]
19. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M
Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232
[TBL] [Abstract][Full Text] [Related]
20. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
Millar EK; Graham PH; O'Toole SA; McNeil CM; Browne L; Morey AL; Eggleton S; Beretov J; Theocharous C; Capp A; Nasser E; Kearsley JH; Delaney G; Papadatos G; Fox C; Sutherland RL
J Clin Oncol; 2009 Oct; 27(28):4701-8. PubMed ID: 19720911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
